Vergoeding 2017-2021 voor ATC-subgroep J05AF : Nucleoside en nucleotide reverse-transcriptaseremmers

  • Raming voor de totale Zvw-populatie
  2017 2018 2019 2020 2021
J05AF01 Zidovudine (Retrovir ®) 43.575 32.785 19.823 13.729 18.608
J05AF02 Didanosine 38.300 648 . . .
J05AF04 Stavudine 905 . . . .
J05AF05 Lamivudine (Epivir ®) 592.810 529.190 424.470 301.640 230.010
J05AF06 Abacavir (Ziagen ®) 585.840 505.680 385.420 302.520 258.500
J05AF07 Tenofovirdisoproxil (Viread ®) 6.491.200 2.534.500 994.490 876.800 675.300
J05AF08 Adefovir (Hepsera ®) 377.140 340.800 246.130 190.890 159.660
J05AF09 Emtricitabine (Emtriva ®) 79.988 57.383 50.287 52.636 43.997
J05AF10 Entecavir (Baraclude ®) 7.478.300 3.425.200 1.484.400 1.641.200 1.324.000
J05AF11 Telbivudine (Sebivo ®) 22.045 24.060 20.327 2.504 .
J05AF13 Tenofoviralafenamide (Vemlidy ®) 58.306 519.990 1.101.300 1.595.100 1.785.600
Totaal 15.768.409 7.970.236 4.726.647 4.977.019 4.495.675